Pathology: la/mBC - HR positive - (neo)adjuvant (NA);
la/mBC - HR positive - (neo)adjuvant (NA) | ||||
NEO-ORB (wild type cohort), 2019 | NEO-ORB (mutant cohort), 2019 | NEO-ORB (buparlisib vs placebo), 2019 | ||
alpelisib plus letrozole | 2 | T1 | T1 | |
buparlisib plus letrozole | 1 | T1 | ||
letrozole | 0 | T0 | T0 | T0 |